Drugs · acquisition-cost intelligence
basic care infants ibuprofen
ibuprofen· ingredient ibuprofenAntiinflammatory preparations, non-steroids for topical use· IBUPROFEN 50 mg/1.25mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.20097
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other ibuprofen products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| basic care childrens ibuprofen | $0.03041 | −$0.17060 |
| 365 whole foods market ibuprofen | $0.03227 | −$0.16870 |
| IBU | $0.04428 | −$0.15670 |
| IBU | $0.05051 | −$0.15050 |
| IBU | $0.05674 | −$0.14420 |
| Advil | $0.08009 | −$0.12090 |
| basic care childrens ibuprofen | $0.15408 | −$0.04690 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.